Trials / Completed
CompletedNCT01665040
Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain
Precision Spectra™ Neurostimulator System for the Treatment of Chronic Intractable Pain of the Trunk and/or Limbs
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to investigate patient satisfaction with treatment using a new implantable neurostimulation system for chronic pain of the trunk and/or limbs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neurostimulation device implantation | Study subjects will undergo a screening-trial of neurostimulation using the Boston Scientific Corporation Precision Spectra neurostimulation system and may proceed to permanent implantation in the event of a successful screening trial. Treatment will include spinal cord stimulation and may also include peripheral nerve stimulation, based upon the physician's subject-specific treatment plan. |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2014-05-01
- Completion
- 2014-12-01
- First posted
- 2012-08-15
- Last updated
- 2020-11-19
- Results posted
- 2019-01-03
Locations
7 sites across 3 countries: Australia, Belgium, Spain
Source: ClinicalTrials.gov record NCT01665040. Inclusion in this directory is not an endorsement.